Patient Engagement and Data Exchange is Driving the Next WaveFor years, technological innovations in life sciences were proving beneficial only to pharmaceutical organizations and healthcare professionals rather than the patients themselves. This was largely because the solutions were designed from the lens of software developers and professionals in various life sciences industries--creating an invariable disconnect with the patients. Despite the influx of apps that were meant to remind patients to consume their meds, share EMR with surgeons, digitally fill out prescription forms and share with pharmacists, compare various drugs on the market, and more, there was an industry-wide consensus that a majority of patients didn't see the upside in leverage these apps. Enter wearable devices. Patients are more engaged than ever since the data collection made possible through wearable technology helps them alter dietary habits, take precautions, and use actionable insights to improve their general well-being. By the same token, clinicians have access to unique data and the biometrics, biotelemetry, and performance data to conduct observational studies, and seamlessly monitor a patient like never before. The level of accuracy has made it seamless for both the patients and doctors to engage in the process of data exchange. Since wearables come with default internet connectivity and automated cloud uplink features, there is easier and accurate facilitation of data exchange. This data cloud also proves beneficial to insurance professionals and heathcare providers who needn't depend on patients for information. The data is also leveraged by medical students and researchers for the purpose of studies based off real-world examples. These trends are leading to new opportunities for the various life sciences sectors--pharmaceutical, biotechnology, or the medical device--and opening the door for patient-centric business models that are designed to improve patient engagement and more efficient data exchange. After all, an engaged patient is advantageous to the other stakeholders in the healthcare ecosystem. While clinical trials, compliance and regulatory mandates, and drug pricing are still top priorities for the industry, pharma companies can no longer sit back and not utilize cognitive technologies such as AI, AR/VR and IoT. They are almost duty-bound to fuse medicine and devices together to enhance patient engagement and drive optimization across every operation in healthcare. EditorialCopyright © 2019 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MAY - 08, 2019, Volume 05 - Issue 17Published by ValleyMedia, Inc. To subscribe to CIO ApplicationsVisit www.cioapplications.com Graphics & ArtManaging EditorJoe PhillipSenior WritersClara MathewEditorial Staff*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffSalesVincent Georgevincent@cioreview.comEmailsales@cioapplications.comeditor@cioapplications.commarketing@cioapplications.comContact UsPhone: 510.330.5174Fax: 510.894.8405Declan ColeAlbert RozarioBen JacksonDaniel HolmesEzra BenjaminJune MichaelPaul BarberLeah JaneRoyce D'SouzaJoe PhillipManaging Editoreditor@cioapplications.comJoe Phillip
< Page 5 | Page 7 >